REQUEST A DEMO
Total
USD $0.00
Search more companies

Gls Health & Biotechnology S.A. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Gls Health & Biotechnology S.A. Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Comercio, importacion y exportacion de equipos medicos y quirurgicoscomercio, importacion y exportacion de productos farmaceuticos y medicinalesasesoramiento empresarial y de gestion como consultoria

Headquarters
Cl 164 19 A 26
Bogota D.C.; Bogota D.C; Postal Code: 1024

Contact Details: Purchase the Gls Health & Biotechnology S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Gls Health & Biotechnology S.A. report to view the information.
Registered Capital:
Purchase the Gls Health & Biotechnology S.A. report to view the information.
Financial Auditors:
Purchase the Gls Health & Biotechnology S.A. report to view the information.
Incorporation Date:
April 19, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
33.33%
Purchase this report to view the information.
15%
Purchase this report to view the information.
15%
Purchase this report to view the information.
1.67%
Company Performance
Financial values in the chart are available after Gls Health & Biotechnology S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
16.44%
Total operating revenue
16.61%
Operating profit (EBIT)
103.37%
EBITDA
152.01%
Net Profit (Loss) for the Period
70.73%
Total assets
38.11%
Total equity
19.17%
Operating Profit Margin (ROS)
6.73%
Net Profit Margin
2.14%
Return on Equity (ROE)
5.41%
Debt to Equity Ratio
23.56%
Quick Ratio
0.53%
Cash Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?